The Lancet January-July 1999: Vol 353 Index

109 Pages·43.8 MB·English

Supplement to
THE LANCET
index volume 353
January—July 1999
Editor Richard Horton
Deputy Editor David Sharp
THE LANCET PUBLISHING GROUP
42 Bedford Square, London WC1B 3SL, UK
655 Avenue of the Americas, New York, NY 10010, USA

index to volume 353 1999
Concordance Pages Date of issue Number Pages Date of issue Number
To enable the reader to determine at a 1-80 January 2 9146 1111-1198 April 3 9159
glance, the date and serial number of 9147 1199-1284 9160
the issue of THE LANCET containing
9148 1285-1372 7 9161
the required page reference.
9149 1373-1454 2 9162
915 1455-1538 9163
February 6 915 1539-1632 ‘ 9164
915 1633-1720 ! 9165
603-684 2 1721-1810 ) 9166
1811-1894 2 9167
1895-1984 5 9168
1985-2084 2 169
939-1026 57 2085-2170 ] 9170
1027-1110 : 58 2171-2256 2 9171
Subject Index
References and abbreviations
i Correspondence Lifeline
Com Commentary J News
E Editorial Research Letters
Es Essay } Seminar
All references to HIV are to HIV-1 unless otherwise stated
Page numbers preceded by sI refer to pages in The Lancet supplement—Surgery
Page numbers preceded by sII refer to pages in The Lancet supplement—Acute Coronary Syndromes
A Support for demand for Acute haemorrhagic oedema of childhood (AHE)
egalisatior ss Europe (Rogers 992 N Henoch-Schonilein purpura relationship and dise
Abuse Of childre 2e Child abuse; Of parents by n brother and sister (Gattorno et al 728 R
Abacavir -DA approval f adult children increasing in ireland (Birchard 1251 Acute phase response Evolution of familia
AAbbbbootkti naLsaebo raFtDoAr iewsar niUnrog N): See also Domestic violence Mediterranean fever and (Tunca et al 1415 R
ty and recall urged (Ault € Acamprosate New aicoh ndency treatment Acute respiratory distress syndrome (ARDS) Damage
Bonn 213 N to surfactant-specific proteins (Baker et al 1232
Abciximab (Hirsch and Weitz 1432 ni Acetaminophen For acute pain (Carr and Goudas Adductor muscle Long-standing groin pain and effec
annhdi bitsiaofne ty of (Tvoonp ol Wietl le al 230)d fa(Scttioegri-edr epeetn daeln t1 18pl5a teCl e 2054); Hepatotoxicity and parvovirus B19-associat tiveness of active physical training for treatment
ed fulminant hepatitis (Bernuau et a! 754 C randomised trial) (Hélmich et al 439) (Gibbon 1444
activation underf { N-Acetyicysteine Renal function improvement in hepa C) (Syme et al 1444 C
Abdominal adhesions As surgical comp
torenal syndrome by (Holt et al 294 R Adefovir dipivoxil Chronic hepatitis B tr
genesis and prevention (Holmdahi 145¢€ Acetylsalicylic acid see Aspirir Dusheiko 1032 Com) (1714 correction
et al 1476 iohnson 2241 C Achondroplasia Pelvic lipomatosis association (Kume hd ine d i defi y Gene therapy
Abdominal aortic aneurysms Early elec et al 1017 C) (Ono et al 1017 C progress (Rowe 2133 N
sltr nographic surveillance (Col Acinetobacter b li Blajyyp gene isolatior Adenoviral MyoD-vector Forced myogenesis
McCleary and Mahomed 408 ( Cornagiia et ai 899 R prenatal diagnosis of muscular dystrophy
Powell and Greenhalgh 409 C); Lapar Ackee fruit Unripe, fatal encephalopathy epidemic in al 727R
assisted reps + al 1765 R hildren (Meda et al 536) (Kupfer and idle 1622 C Adenovirus infection Left ventri
Abd. A ij diol
BY Quere et al 1623 C) (Sherratt and Turnbull 1623 C Senior 988 N)
Dondelinger si15 Acronyms Excess use in medical publications (Sharp Adhesions Abdominal, as surgical compli
Abdominal pain Carnitine deficiency assoc 1728 Com); HAART (Edlin 1888 C); TTV (transfusior genesis and prevention (Holmdah! 1456 Cx
sodium valproate in epileptic (case rep transmitted virus) (Zuckerman 932 C et al 1476) Johnson 2241 C
Actinomycosis Possible diagnosis after unilatera Adolescents Brain structure and
Abdominal wound Influence of ropharyngeal symptoms and tonsillar cancer differ neurocognitive /b ehavioural funct
omplications after surgery (randomised study ential diagnosis (case report) (Salib et al 2124 very preterm (Stewart et al 165 Buccal n
Niggebrugge et al 1563 Activated protein-C resist In pregnancy associat lam vs rectal diazepam for seizure treatmer
ABH biood group antigens Non-secretors, uropatt ed with increased thrombin generation and feta! domised trial) (Holmes 608 Com) (S« tt et
genic E coli binding and recurrent UTIs (Stapletor weight (Clark et al 292 R) (Kiuft et al 1882 C Ellis and Baddely 1796 C) (Scheepers et
Con Activation-induced cell death (AICD) Of T cells Scott et al 1797 C) (Chattopadhyay et a
ABO blood group improvement of preoperative frag ncreased by interferon Bit in multiple sclerosi Pregnancy in and UK campaign to reduc
ment prothrombin 1,2 in orthopaedic surgery (iturbe (Kaser et al 1413 R Scally 2178 Com); Tuberculosis preventior
et al 2158 C); Response to inhaled nitric oxide in Active specific immunotherapy (ASI) For stages !!/I!! 1001); Warnings on smoking dangers (Bo
hildren associated (McFadzean et al 1414 R lon cancer (randomised trial) (Vermorken et al N); See a/so Young people
Abortion Anti-abortion activists’ trial in US (569 N) 345) (Blot et ai 1524 C) (Bremers and Parmiani Adrenal insufficiency Functional, ir critically
Australian Capital Territory law (50 N); Injunction 1524 C) (Lukacs and Davies 1 C) (Vermorken et patients (Beishuizen et al 1675 R)
against protesters in Ireland (Birchard 993 N) (g-Adrenergic agonists Acute pain management (Carr
Internet anti-abortionists sued by US doctors (Oregon Acute coronary syndromes see Coronary syndromes and Goudas 2056
Rovner 303 N); issues in Ireland and Northern acute Bg-Adrenergic agonists Impaired response in asthma
THE LANCET ~ Index to Vol 353 - 1999
Afghanistan Alatrofloxacin ¢ y warr by EMEA
Adrenergic pathway Albania Rape rs for
Albanians / ga
Adrenergic receptors Afipia felis
, Adrenergic receptors
Albendazoile
7Adrenergic receptors Aflatoxin By +
Albumin
Afiatoxins Alcohol
Adrenergic-receptor kinase ((sARK)
Africa
Adrian E D
Adult Diarrhoea Rotavirus (ADVR)
Adult respiratory distress syndrome (ARDS)
Adult T-cell leukaemia/!ymphoma
Adverse drug reaction (ADR)
African trypanosomiasis £
Age
Aldosterone/renin ratio
Age-based rationing
Age-related macular degeneration Aidosteronism, primary
Ageing
Algeria
Allele-sharing method Hyperte
Aggrenox
Agriculture
Allergens
Aid agencies
AIDS
Allergic rhinitis b
Allergic rhinoconjunctivitis
Allergy
Allograft rejection Vi
Allografts
Alteplase
Alternative medicine We
Altitude High altitude
Kyrghy
Altman L K (684
Altschuler E L (1538
Adverse Drug Reactions On-Line information Tracking Alzheimer's disease Abr
(ADROIT)
Adverse effects AIDSVAX vaccine
Air ambulance Ur
Air pollution Effe
Advertisements
Advertising stial de J : f
pairme 5€ 1072
AmantadineP neumonia risk reducedi n strok
patients (Nakagaw R : ‘
156€ Sek awa et
bag-Lanoe
Amazonians Symptomess
Ad(vAiCsoRrEy) Commb ittee€ on Ret leases 5] to the Envireto nment Air travel Deep-vein thromt Ambulances Rapid prot ier cain iii titi
American Academy of Pediatrics (AAP)
Aesculapius
American Coliege of Cardiology Evider pp :
Affirmative action | erventiona rdiology Hu 9 N
Airbags Av n of pit
re e prevention (Huster
AkpinaCr Turkish doct t American Diabetes Association Benefits of j
THE LANCET - Index to Vol 353 - 1999
amblaoct ennJ ‘FaOsmei ly Phntyrsoli cia(nH opWkeibnssi te2 215( AshrN af 156 trair g (Mopnoltymgoroptem tie sarml y5a4 n1d rBeespeocrh 18804 phCy sical 1h8o5t8h erN)a; py Covms panreifsaozno doonfe triocr yclpiscysc,t SoSthReIrsa pya nd Benratmuarra l
American Joint Committee on Cancer (AJCC) Genotype and high altitude pulmonary hypertension medicines (McCarthy 107 3 N): Ir postherpetic neu
nterferon adi therapy for melanoma (As ert risk (Morrell et al 814 R ralgia (Dworkin 1636 Com
RRR ORNTENS enzyme (ACE) inhibitors — Antiepileptic therapy Risk of StevensJohnson syr
American Medical Association ——* Agr eeme t with Angiogenesis induction (in rabbits) (Husten 213 jrome and toxic epiderma necrolysis
3 Lundberg negotiated (McCarthy 5 N); Failure t Aspiration pne nia prevention in elderly hyperter 2190
ega edibility after sacking f AMA editor-in-chief sives (Teramoto and Ouchi 843 C); Captopril vs cor Anti-GBM nephritis (Couser 1513 S
Horton 39 Sacking of editor-in-chief (G ventional antihypertensive therapy in CAPPP trial see Antihaemorrhagic drugs Novoseven cost ir
iberg) of JAMA (Horton 252 Cor Minuth 1104 Captopril; Mecnanism of action (Montgomery et al Switzerland (McGregor 910 N
C) (Shiwach 1104 (¢ 41); Trandolapril in diabetic neuropathy (Stoschitzky Antihistamines Fexofenadine and life-threatening
American Society of Clinicat Coy H© igh-dose 326 C) (Bell et al 927 C) (Malik et al 927 C arrhythmias and QT lengthening (Pint et al S80 R
hemotherapy for breast cancer trials yr ve Angola Polio outbreak (McMenemy 1688 N Giraud 2072 C Pinto et al 207
E Animal feeds Dioxin-containing food crisis due tc Antihypertensive therapy Effect of FACE inhibitors v
toime he anagement (Gabbarir Ashraf 2049 N): Vancomycinresistant enterococc on cardiovascular mortality in hypertension (CAPPP
e-living hospita nd Afipia 1s1o9l0a tionC in USA (Schwalbe et al 722 R) (Kilopp randorr Liims ed 17t9ri3al ) C) (Cu(tSlecrh ee6r0 4 HaMnesssseornl i et anad
felis association (La Scola ar R Animals Laboratory, increased efficiency of use Grossmar 9. 4 C) (Wiggam et a
Amoxicillin Res sistance in Helic 154 cor Hagelin eta l 11 C) (Hauswald 1977 C 1 Brown 1 C Gueyffier et a
t andi 241 Teare et al 242 ( Anorectal incontinence Surgery (Williams si31 Hansson et 5 C); increased use results ir
Amygdala tHippocama complex Small, in group at Anorexia nervosa 5-HT>, gene promotor polymor reduced blood pressure and cardiovascular diseases
gh risk for sct enia (Harrison 3 Com) (Lawrie phism and (Collier et al 929 C) (Ziegler and Gérg 929 Mitchell 1503 N); Optimisation by crossover rotatior
ta C); Compulsory hospital admission (Bosch 993 N of four major classes (Dickerson et al 2008); In very
Amyloid Ba for familial British dementia (FDB Antarctic House dust mite and cat allerger 1 patients met 2-analysis Gueyffier et al 793
Senior 2216 h tion (Siebers et al 1942 R Oster and Schlierf 2243 C WHO-ISH guidelines for
Amyloid plaques preclinical” Alzheimer's disease Antenatai diagnosis Duchenne muscular dystrophy ypertersion management Bradbury 563 fh
Larkin 81 J Bushby et al 557 R) (Zalaudek et al 197 Anti-inflammatory drugs Underuse in cystic fibrosis
Amyotrophic laterai sclerosis Leukaemia inhit tory Antennapedia Entry into cells (McCarthy 2 Wunsch 1335 N
actor expression in skin (Hu et al2 126 R Anthrax vaccination Punishment for US m Anti-inflammatory properties Of statins in CHD
Anaemia Aplastic in donor cells after bone-mar row sonnel refusing (Morris 130 N Strandberg et al 118 R) (Ikeda et al 1274 C) (Kluft
transplantation (Melenhorst et al 2037 R yey no lifestyle Atopy reduction (Strachar et al 12
T Aim et al 1485 Anti-ischaemic therapy |n acute cor nary syndrome
yrimethamine in malaria in pregnancy (randomised authtoe antibodies in polymyositis and tacrolimus Verheugt sil2¢ See alsc &-biockers; Caicium antag
tria St man et al 632 therapy (Oddis et al 1762 R nists; Nitrates
Anaesthesia ai, for a ain (Carr and Gouda Anti-TNF Trial in Rheumatoid Arthritis with Antimalarial drugs Combinatior ther apy ano res
7 4); N xide, spastic paraparesis after Concomitant Therapy (ATTRACT) Results Jack tance White et al 1965
wing to vit 12 deficiency ase report 32 N 4 Antimicrobial agents Group B streptoc« cecal infe
54) (A learlove 1446 C) (Maya Antiangiogenic agents (Rowe 732 N); Age-related prophylaxis (Schuchat 51 S); Preventior of recurrer
€ erative asting and time reductior S re nacular deger eration treatment Sen or 818 N urinary tract infections ir women Stapleton 7); See
502 C T imnacr eta 162 4 Sr 224 smith 162 4 Cc Atherosclerosis treatment Bra Jour also Antibiotics
Anal flesure Anal herpes masquerading as (case 1334 N); See also Angiogenesis; Endostatir Antimony High levels associated with idiopathic dilat
report) (Winceslaus and Schofield 1672 pst pnaags drugs Class II! (ibutilide) and acute ed cardiomyopathy (Husten 1594 N
Anal Benpes Masquerading as anal fissure ASE rena after (Franz et al 467 R); Implantable Anti-obesity drugs Criteria for use in Royal College of
report) (Winceslaus and Schofield 1672 ardia ator (ICD) vs (MUSTT study) (Husten Physicians report (214 N
Analgesia Cancer pain management (Portenoy and 903 I Anti-cestrogens Multiple myeloma treatment (Gahrtor
esage 1695); 8-Endorphins delivery into spinal cord Antibacterial activity Of hyperforin from St John's 85 Com
by gene therapy vectors (Mitche wort against MRSA and gram-positive bacteria Antioxidant effects Of herbs (Warren 676
tior ve npp et al 2129 R Antioxidants Role in rhabdomyolysis to reduce lipid
ne annabinoid analogue Antiblotic resistance Amoxicillin in Helicobacter pylor peroxidation (Holt et al 1241 R
act Jependent of opioid recepto Hamann and 154 correction) (Guslandi 241 C) (Teare et al 242 Antiph holipid antibodies (Greaves 1348
Ji Vad R); See a Pair C); Carbapenem-hydrolysing IMP-1 8-lactamase ir Thrombosis and (Greaves 1348
Analgesics For a n (Carr and Goudas 2054 Klebsiella pneumoniae (Koh et al 2162 C Antiphospholipid synd Greaves 1348); Diagnos
nor pa mar t (Porter ang Lesage sistant Salmonelia typ Threlfall et and management (Greaves 1350); Recurrent miscar
riage (Greaves 1351
Ana1€p h9y8l axi >s€ An21tSi biotnidcisv idu rting and patients jevfeulnodpinmge nt f USof geRneotvincearl ly 12°m odiNf ied Antipiatelet drugs |n acute coronary syndrome
at-risk (Pumphrey and Davis 1157 8 rops/foods and risks (Beringer 605 Com) (Crawford Verheugt sli21); GPilb-lila blockers et al 22
Anatomy 3D in Visible Human Project (Rowe 46 N 1531 C); Imipenem in Acinetobacter baumanr Stiegler et al 1185 C); New agents (H
Ancrod Therapeutic use and actions (Senior 1946 N Cornaglia et al 899 R Aultiresistant enteric gram 1431) (1804 correctior
Androstenedione Adverse health effects and failure t negative bacilli and sepsis increase (Duke and Antiproliferative agents |n transplantation (Denton et
astre ngthen Abmduosmcilneas M1i2c0h1a el Com)2:2 10 Ir R); opStartehpotgoeconcsc us apnd neucymstoitnisi aetr eatment Anatl ip1r0o8t6e asNe therapy !n ARDS reduce
aneurysm yr Senior 731 N): Vancomycin-resistant enterococci see sur factant-specific proteins (Baker et al 1232
ura et Vancomy stant enterococci; See also Meticillir Antipsychotic drugs Schizophrenia (Schultz an
eport) (Cohen et a resistant Staphylococcus aureus Andreasen 1428 S)
jen deat nelioidosis (Torrens et al 1016 ¢ Antibiotics Anaphylaxis under-reporting and patients Antiretroviral therapy Abnormal! body fat distributior
Angiitis Of CNS, presenting as rapidly progressive at-risk (Pumphrey and Davis 1157 R hlamydia HIV-1-infected children (Babi et al 1243 R
Jementia (case 1151 pneumoniae infection and reduced acute myocardial Compulsory drug licensing in developing countries
— — ng-term nitrate therap d toler tion (Senior 472 N); For community-acquired McGregor 1 165 N): Definition and measurement of
ance pre treatment (Glasser 1 Cor pneumonia (Holmes et al 1528 C); Demanded by US adherence (compliance) (Lazzarini et al 841 ( Mur
Refractory hirudin vs heparin (randomised trial parents (564 N fopment and patenting issues et al 1974 C V genotypic-resistance testing ar
Wallentin 423 Com) (Organisation to Assess 1721 E): Enoyl-acyl carrier-protein reductase (ENR choice of agent (VIRADAPT randomised trial) (Falloor
Strategies for Ischemic Syndromes (OASIS-2 aS new target (Larkin 11 N); Inhaled, efficacy ir 2173 Com) (Durant et al 2195); HIV-1 replicatior
vestigators 429); Transmyocardial laser revascular ystic fibrosis (McCarthy 215 N); Peptide and contra nhibition goal and evidence of ngoing replicatior
sation (TMLR t beneficial (randomised trial eptive potential (Sawicki and Mystkowska 464 R with HAART (Natarajan et al 119 R risk of
Prétre and Turina 512 Schofield et a Re-emergence of Saimonelia typhi sensitive to chlo new AIDS diseases (Miller et al 463 R); See a
Horvath and Kadipasaoglu 1704 C) (McMurray ramphenicol (Sood et al 41 R Highly active antiretroviral therapy (HAART
1704 C) (Lansing 1705 C) (Moosdorf 1705 C Antibodies Neutralising in control of HIV infectior Anti-T-cell globulin (ATG) In bone marrow transplanta
Hetzer and Krabatsch 1706 C) (Schofieledt al 1706 Morris 471 N tion and aplastic anaemia recurrence in donor cé
1714 correction) See a'so Coronary syndrome Anticholesterol drug OTC sales planned in USA (Ault after (Melenhorst et al 2037 R
acute and McMenemy 1339 N); See a/so Cholesterol lower Antithrombotic effects Of red wine mediated by nitr
Angio-oedema Associated with Cr \ ng therapy; Lovastatin xide and mechanisir of French p: aradox (Sir
tis and complicated by corticosteroids Anticoagulants |n acute coronary syndro mes 1944 N
Sreenwald et al 2208); Hereditary, pr Verheugt sil21); From snake venoms (Senior 1946 Antithrombotic techniques Thr ymbosis ir
JBaonrakz ole t aar n h1e6p6a toR)c el(lAubil ar adea noma* s assoc atior N)n ; prNeegwn anacgye nts( Gre(eHri rsc1h2 62a nd Weitz 1432); Thrombosis ouGdre er 12r6e2e + +
Angiogenesis Endogenous inhibitors and role f tro Anticoagulation |n atrial fibrillation (Omran et ai 591 romes Verheugt sil21
ponir Rowe 1072 N): Endostatin action and cancer C): Deen-vein thrombosis (Lensing et al 481 S) agents Hirsh and Weit
therapy prospects (Rowe f nduction by ACE Malhotra 1708 C); Duration of therapy in deep-veir New agents (review) (Hirsh and Weitz 1431) (1804
nhibitors (in rabbits) (Husten 2132 N); inhibitors see thrombosis (Lensing et al 483 S); Genetic control orrectior ir unstable coronary syndrome and ind
Antiangiogenic agents; New mechanism for inhibitior based on polymorphisms of cytochrome P450 cations (randomised trial) (Wallentin 423 Cor
and roloef a/®& subunits of ATP synthase (Rowe 1072 CYP2C9 (Mannucci 688 Com) (Aithal et al 717 Organisation to Assess Strategies for Ischen
N); Renal cell carcinoma, vascular endothelial growth Aithal et al 1972 C) (Halkin and Lubetsky 1972 C Syndromes (OASIS-2) investigators 429); See als«
factor and platelet counts as prognostic factors Longer duration needed in thromboembolism Thrombolytic therapy
O'Byrne et al 1494 R) (Schwarz 2158 C) (Gunsillius McCarthy 1159 N): Low-intensity for non-valvular Antituberculous drugs Resistance by Vycobacteriun
et al 2247 As triggering factor in rheumatoid atrial fibrillation (Lip 4 Com) (Dalton 756 C) (Lip tuberculosis Kato-Maeda et al 1709 ¢ ee a
arthritis (Hirohata and Sakakibara 1331 R 1620 C) (1978 correction Multidrug resistance
Angioneogenesis see Angiogenesis Anticonvulsants Chronic pain management (Ashburr Antiviral agents Chronic hepatitis B treatment
Angioplasty see Percutaneous transluminal and Staats 1867 Dusheiko 1032 Com) (1714 correctior New rt
angioplasty (PTA) Antidepressants Chronic pain management (Portenoy novirus receptor inhibitor tested for use n commor
Angiotensin-converting enzyme (ACE) Gene inser and Lesage 1698); Combined nefazodone and psy colds (Senior 1769 N); Postherpetic neuralgia pre
THE LANCET ~ Index to Vol 353 1999
Anxiety Audit
Association of the British Pharmaceutical Industry Auditory cortex
Anxiolytics (ABP!) t
Aorta Auditory hallucinations
Association for Cancer Research |
Aortic aneurysms Association of Research Ethics Committees
Aortic dissection Auditory stimuli
Asthma
Aortic pressure Aura
APACHE Ii scores Australia
APC gene
Apnoea
Apolipoprotein E (apoE
Apomorphine
Apoptosis
Appendicectomy
Appendicitis
Archaeology
Australian Academy of Science (AAS) |
ARIC study Asylum
Australian Federation of AIDS Organisations (AFAO)
Arrhythmogenic right ventricular dysplasia (ARVD
Ataxia telangiectasia Austria
Art
Art, Department
Artemisinin derivatives Atheroscierosis Authors, medicai
Autism M
Arthritis
Autoantibodies
Atherosclerosis Risk in Communities study Autoimmune disorders '
Articulation Autoimmunity
Asbestos Atherosclerotic plaques Autologous haemopoietic stem-cell transplantation
Asbestos diseases
Athletes Autonomic failure
Asbestosis
Ashworth Hospital
Autosomal! dominant hypocaicaemic hypercaiciuria
Asia (ADHH) € t R t
ATM gene
AVANTI trials
Asian community Atopic eczema Avoparcin
Asian women Ayurvedic medicine
Atopy
Aspergillosis Azithromycin
Aspiration pneumonia Azoospermia |
Atorvastatin
Aspirin
ATP synthase
Back pain Low ck a 5t
Atrial fibrillation
Back surgery eded ark O88 I
Bacteria t t
Attention t by t withdrawal (M
Attention deficit hyperactivity disorder (ADHD)
ATTRACT trial Re ts of infliximab treat Bacterial infection Acut«: Lf J a ardial 4 infar>
; thrit _ € h Pathogene s of varicea ¢
Attractiveness Bactevf rialn e vaginoGsoius |GeFt- 1 al bin1d3i9n g protein-1 3 in cerv2 ix a
Atypical squamous cells of undetermined signifi- ne ' f t ns ena
cance (ASCUS) HPY test tor e borderline
Assisted-suicide F na € a 33 I Bacteriology History (Mortimer 581) (Dane eta
Association of American Medical Colleges Audio-computer interviewing Risk behaviour f 44 Penniannd gMcKtenzoien 1 44
THE LANCET - Index to Vol 353 - 1999
BIOMED programme EUTERP study (Cornu 63) (Drum Com); French ministers acquitted ir nfected bi
and Eichler 929 C Garattir and Bertele 930 C trial (Durand de Bousingen 992 N French ministers
Bacteriophage ysoger Biomedical publications Geography in EU (1990-98 yn trial over scandal (Durand de Bousingen 653 N
xin encoded by (Beut Hefler et a 1856 R): See als Medical publications Italian safety scandal and incorrect allegations over
Bacteriuria Afte Biomedical research Campaign t increase funding ir former Minister of Health (De Lorenzo 1364 (
Balkans Effect Canada to stop brain drair Ferry 216 N); Trends and Taintec-biood settlement for secondary infectior
sdget an ai Science Foundation small bud spouses/parents) in Canada (Kondro 47 N
142 omparison (US) (Greenberg 1421 fh N); See Blood transfusion Bayer'’s Advisory Council or
Balloon atrial septostomy Pulr 7 Medical researct Bioethics (Cash and Boyd 691 Com); Enzyme
treatmen Higenbottam « ] Biopsy | rge-core needle vs surgery in bre replacement therapy by, for trioser osphate
Bangladesh DOT strategy Senior 1595 merase deficiency Ationu et al 1155 R)
BloResonance Therapy (BRT) Promotior Witnesses (Wilcox 757 ( Self-sufficiency
Larnin 3s Birchard 2221 N SHOT scheme report (9¢
Biosensors RF es toring antibody rans sion-transmitted virus (TTV) identified
response t > holson et al 808 R 300 N S recipients at risk of HCV t
Bioterrorism strategies Ault 1686 N
n US (Franke Blood vessels Changes in mesencephal
Basic fibroblast growth factor Bipolar disease C hildrer P arkinson's disease Faucheux et al 981
se drops for Kapos sarcoma Bermar 774 omega-3 fatty Changes wall as risk factor for venous
Sayes came Counel on Bioethics Verougstraete 2158 C); Growtt see Angiogenes
Biood-bank Blood donation scree 5 for HCV, HBV
Birth Postr and HIV-1 by PCR (Ro
Bayer Seundatien | ng Bayer Ac 343 Con 1441 C) (Winceslau
n Bioethics Birth rate | and Seifried 179¢
B-cell leukaemia agampbe Blood-brain barrier Distur t
gadolinium-enhanced MRI for relapse
hanges :n multiple scleros Kappos
Kannus Blood-gut interface (Marston 1875 £
Schwat Body composition ACE gene insert
morphism ano (Mc ntgomery e
sistance and diabetes as 1884 C
Hattersley ar Body fat Abnorma Jistributic
valence atop: jren on antiretrovira!s (Babi ¢
Beadle G W Sety mass index (MBuMllIi)g anC han4g1 e
Beagiehole H L Bishop R F¢ ring (Voss and Mulliga
Becker muscular Gaus < Jevelopment VOSS ar iMigan 2070 C
at Bisoprolol Approva attrac tiveness and Ma Sey €
jerate eart f Body-building supplement Failur«
to strength muscles and advers
Birchard 1943
Body-packers P
Marc and Baud
239
Bisphosphonates |r Bolivia Yell
85 Corn Monatt
Bites D Bone Archaeological mystery
Bladder FDA Birchard 1337 N); Biopsy
ase report) (Olive
netaboli nineralisatior cause
Behavioural therapy Chr al papillorr cadmiur Staessen et
Ashburn and 1 keratin 20 expres Harnden et < ed with environmental exposure
Morris 128 N Bladder cancer Antitur nune respons Staessen et ai 114 Graft
Beigium Dioxir Alexandroff et a 92 BCG immunotherapy Heest and Swiontkowski si28
Benzodiazepines review) (A { t al 16 ncreased drinking bone morphogenetic proteir
4 acy adc 1682); Risk Bone cancer Treatn ent refusec
Sx meat at nor Kondro 1078 N
Schee pers Augustsson et Gene marrow Reinfusion, effe
Chattopadhyaye t nin metabolism Wymenga et
Bradbury Bone marrow transplantation Ap
blaimp —~ a m Acinetobacter bau rence in donor ells after (Melenhors
Beriberi see straini n Eu > (Cornagiia et al 899 R Gahrt
Bg-adrenergic poner see B- siooding © licatior th warfarin and p as ar
§-blockers| n acute phisms of cyt C re CYP2C9 (Mannu 688
e jer Corr Aitha . 1 ia 1972C Halkir
and Lubetsky ; ee a Haemorrhage of haemopc
Blindness WHO rogramme elirnination (Morris and future prospects (Leiper 1
also Visua limus refusec approval by FDA (305
Blood uation FDA ban on UK blood 2050 N Bone morphogenetic proteins (BMPs) |B MP-7
orre FDA rect ymmendation for deferra ns (Bonn 650 N Regulat
resider ts ir R screening applications in fractures and rené
and
1799 aan pain Hypovitaminosis D due t
gn realtdee rlwy myoc 1 C) (Wincesiaus 1441 C eatf teral 8s0m6a)l;l Pboawmeil drorneasteec-tiionr
Barakat et Bioo: du Blood transfusior and increased ytokines
Betaferon see interferon beta-1b sitors to Canada Haworth et al 1886 C
Betamethasone Antenatal adr Kondre Bosnia Medical consequen
p1i4a0 4)e ntal( Movnatsecnuelgarro re2s(i stance BBlloooodd gmluuccoossael sheaer riGelru coFasiel ure 3nd effects (Mars Rheeaslttohr ateifofne cts of ohfe alwtahr (Hcoarret
Bezafibrate For tamoxife 1875 Es Bovet D (Raju 1981
Bisatse aAtgoahienpsatt itEiusr ope >aari dara Seer d (pO'rBreisens uraen dA mSb: tualeastsoerny m4o1 5n4i1t oriConmg) ; andD5 iugrunia jelines BoCvoidneex report and i doubts
Jatabases N Nieminer rhythm and effect on haemorrhagic cardiovascular Milk safety questioned
Alati matrnia l 4r¢e portiGnrg een(wRoo i ChLoariemnezr s 12a7n7d C e1v80e0 nts ¢ ManMfarnedfirneic et eta l al6 431 80R0) C)(:K ariEof feacntds Poifc k¢ ering D3D0O6< U N fh \ Moratorium in UK
nica J aceutical compa ng water (Jorcar 23 R) Uordar Bovine spongiform p
nies (Warlow et al 22 Beert pane! in breast Senard et al 1971 C); Measurement, training to nvCJD cases and lessons
mplant case Sharp assessme nt for students (Franke 1858 N Inquiry report due (Jur
BilCirouobkien S1y8r 14h esCiosn rec cterus preventior PN)r; ediRcetdiuocne d andb y reT'laai tiCohnis hiinp toe ldesrtlyr ess( Morrreiss po9n0s4e N toni mettoansbill e spSeecniiomre 1502
Bioethics Bayer Advis Reduction witt vitrendipine in vascular demertia pre BoysC ancer treatme
Com vention trial ( Syst-Eur) (Pahor et al 235 C Zuccala Canada (Kondro 1078 N); Circumcision (Fis
Biofeedback Urinary ir ontinence treatment (Morris et al 235 C) (Forette et al 236 C) (Leys and Pasquier 669 C) (Dalton 67 Van Howe and Cold 67
128 N 236 C) (Kario and Pickering 1184 C) Trandolapril Brain Activation during hypnosis (Larkir 386 N
Biological agents C jorectal cancer treatment ise ir jiabetic neuropathy (Stoschitzky 926 C) (Bell Activation increased by oestroger n postmen
Midgley and Kerr 398 S et al 927 C Malik et ai 927 C); See ailsc women (Bradbury 12 Albert Einstein's
Biology implications of ageing and gains in quality life Hypertensior Witelson et al 2149); Damage by drugs «
years (421 E Biood products Ban |ifted for products from CJD donor nancy (Bradbury 126 N); isolated angiitis
Biomaterials |n extensive burns management (Harris in Canada (Kondro 132 N); Bayer Advisory Counci senting with rapidly progressive dementia (c
et al 35 R) on Bioethics reports and role (Cash and Boyd 691 report) (Bornke et al 1150); Mesial orbit
THE LANCET - Index to Vol 353 - 1999
C
Breast cysts t CA 125 antigen
Breast implants CADASII
Cadmium
Caduceus
Breast milk Caesarean section
Breastfeeding
Brain cancer
Brain death
Brain drain
Brain natriuretic peptide (BNP)
Caicineurin
Brain proton spectroscopy (MRS) Breath tests Calcineurin inhibitors
Brain surgery
Brazii
Brill-Zinsser disease Calcium
Bristol case” surgeons
British Biotech
BRCA1 gene British Medical Association (BMA) Calcium antagonists
Calcium-sensing receptor (CaR) A
BRCA2 gene
British Medical Journal
British Nuclear Test Veterans Association (BNTVA) Camel bones
Breast Canada
Broca's aphasia
Broca's area
Breast cancer Bronchi.| hyperreactivity
Bruising
BISTEPS
Budesonide
Buffalo hump
Bug zappers
Bulgakov M
Bulgaria
Bulimia nervosa
manatee hydrochloride
aaetia
Cancer
Burkholderia
Burkholderia pseudomallei infection (melioidosis)
Burkina Faso
BurnetF M
Burns Ext nent by hya ;
Buruli ulcer Vy acte rans tra
THE LANCET - Index to Vol 353 - 1999
; : lowering the gy of tonsillectomy tissue (Saliebt al 2124
Case Report series, correspondence Diabetic muscle
pecif J 4 i ay ) Tang et al 1095 ¢ acti presentir gv with fever V and le
Cancer Research Campaign (CRC) Cancer viva rrington et al 1096 C) (Wight 1096 C) (Robsor , indiK ection ee (W : De sla] t
atic ) Risk and hormone replacement therapy
} f at ] ting aUS t J
06 . ‘ 2) 8 Sudd t rd 4 jeat Cha r al 1a8 81 a C);J ICE SpaW U f erai € afte 3 |t Me x
Cannabinoid analogue Nat e, analge ffect inde enopausa!l wome 3 rrectior S rate anaesthesia owing ta B12 de
endent i receptor 4 j ) e (Huste 2¢ 2 C lia and Deariove 1446 ( Maya ,
¢ b € aS€ rn y Case-cohort studies Coronary heart disease a
Cannabis (marijuana) B« haen ear ease wrotid atheroscler wediction f
M lat f alat ) Cardiovascular effects Of drinking water rdar evels (Nawroth and Har
2a naa eta A Fa |
88N ); Psy CardozoL (938 Case-control study A1/A2 poly
3 xa darriga CARE Aid worke jiled in Sert Morris 195 te a and risk ir ronary cathete t
é i al Narcot Carnitine deficiency |n epilept hild a ate IUl€ 5] oS Afte we ana yracte
ard (M 5. ‘ n vernment NU valproat nd presentinwgi th abdomina
5] es at granted B-Carotene eSru pplements linked tta ance~~r (McC é [ nd - f
k (N é 7 H k
CAPPP trial se« apt Prevent Project (CAPPF Carotid artery dissection After attempted strangula a pt N }
Captopril A ene juct abbits) (Huster t presenting arm weak Malek 48 € te wit
a } ature C k (Baird
tality in hyperte Carotid artery thrombus Direct MR! in acute ( raper et a 7 AE €
} ef me ] ] e vw } ]
Captopril Prevention Project (CAPPP) Effe \CE Carotid atheroscierosis Asymptomatic, thromt 824): Risk factor j jeatt
N 888 Risk i 1d (
Ha Haring ye r Sa 3a et al 1729): Dete r 31 693): Risk '
jrome and tox pide
ant p ept € if F 3 ta ,
Casp3 protein A; fH
therapeutic str McCarthy 1
Carapenems |MP-1 &-lact ASE Kile i pne k informatior yd et al 645 R) (Gattellari et Cassppoats e-1 In nhHiubinttiionn gt (M j . i
Carbamazepine Ac\v € € any 21 Caspase-3 Tat fusion prote and «
Carbohydrates f f j i art McCarthy 2134 N
Carpal tunnel syndrome Yos Cat(s) Infect fr bites by
al ° Carroll, Lewis Migraine expe es (Pod } Cat allergens Passive tra
Antarct sevder eta
Carbon dioxide Retent bstructive sleep a é ound hild ae ty sea pproved in Japa Cat scratch disease Afipia f
and Ra t 1330 R
Carbon aanuanis Fr ve ast case management € € tandard f Catalonia Drug «
Catalytic converters
Carbonyl arenas Ri € aflat By c ‘S hattner 19 .
Caterpillars Ha rrhag ynd e due to a
Carboplatin at erapy vs in ovariar Case Report series Acquired factor x hibitor ca
at et al 36 f g€ and chest pain (Standen et ai 19 Cations lipid ’ rR saan ° - fe
i G ] BS ISsq £ anal f
Carcinogens Toba etabolite f ata é Wincesla j Ar e ) CBFAL eae binding taster oa) a t
av ne at er h at j 3] f ]
Cardiac arrests ediate cardioy nary re ) y t steroid are ) 8); At CD4 colts cs t “ . . t ad )
‘ ‘ exterr : f tr k 1€ ] atepy (Dent
LZ24C . at t
Cardiac arrhythmias L ife-threate after fexofena 1492 arnitine deficiency in epilept
e (Pinto et al 980 R) (Gira Pint 3t ¢ t abd. ; 1 + ack » dif . P v
a f ] t
Cardiac events amydia { 2 k ur tair falet eal k132 4): CMV infection a:
aft re € et 8
Cardiac failure see Heart failure esenting with rash and knee swelling (Hogartt CD18 (53) Defect in leucocyte adf
Cardiac hypertrophy Pathogene and prevent 1 978 ng ta pt ind Jarisch-Herxheimer
CD3T c3eil recog ind aplastic a
bit Ff t 0 ¢
Cardiac Insufficiency Bisoprolol Study II se« BIS feve welling and leu ytc Y king infect
CDst3em 4cel ls Bone marrow repo
Cardiac output f nary hyperte
Higer ttam eta 38 ( veira et al 2 4); Gynae aStia after drinkir CD38/CD8 Expr 1 HA
Cardiac surgery puter-a te arpentier et a female urine (Viernapper and Nowotny 64
ak pa € x€ a | ] at CD45R0 cells HiV-1 treatment rv t
tive FISH (Patteresto nal 211 R
5 54 ‘ pa nyr ing eta 5 _
Cardiologists DeBakey M but and rk ta { fa alabsort aft Celecoxib (Celebrex) (Hawkey a
Larkin 14 N); Paedia } t é present th le we ( Hawkey 1440 ( F proval (22
aS¢€ pe ne and bone pa Mingrone et al 80€ 1 Celera Genomics Human ger e sequel
Cardiology Acronymania (Sharp 1728 ¢ angiit f CNS (IACNS) presenting as rapidly pr stenting issue 1721 E); Human genome
ng timefranad mpreog ress (Larkin 2218
nm ten 9 h Macropr 5] € f € ere i Cell membrane Porosity induced by ultra
Cardiomyopathy |d at jilated see Dilated ca naemia in pregnancy and misdiagnosis (Heaney ¢€ € ikaemia cell Tachibeat nala 1 409 R
Centenarians L<« f n healthy age
Cardiopulmonary bypass N¢ behavioural sequelae thiar Kantha 22
Seines 31 16 Hill n et al 1584): Mesial orbitofrontz Centers for Disease Control and Prevention (CDC)
Cardiopuimonary resuscitation Cerebral hypoxia after esion after subarachnoid haemorrhage causing New childhood immunisa and va e re
Schreiner and himann-Ede
ye external defibr
jiac arrest er Central America Measies eradicat Franke
Cardiovascular disease Alco nsumption effect ir t Central d: iabe>t eRs insipidus w-up (Charmanda
eiderly (1246 N); Effe Brook
THE LANCET + Indto eVoix 35 3 - 1999
Central nervous system Chest China infliue A H3N2 stra itbreak (Brad
Chest pain A ia 5] at
Central pontine myelinolysis
a
Cerebellum art Chlamydia pneumoniae Acute yocardia
Cerebral atherosclerosis Chest radiography fF
Chiamydia trachomatis |r
Child abuse 4
Cerebral atrophy
Chioramphenicol R
Cerebral haemorrhage Child health
Chioride R
Cerebral hypoxia Child safety seats
Children Abnorma
Chloroquine ) -
Cerebral infarcts Cholera gy a (Agarwa k
Cerebral macroangiopathy
Cerebral microangiopathy Cholestasis Pros e fa }
Cerebral palsy Cholesterolowering therapy
Cerebrospinal fluid (CSF)
Cerebrovascular disease
Cervical cancer
Cholestin
Cholinergic agonists 4
Cholinergic pret
Pet watt placental T
Chorionic villus comeing V )
Choroid plexus rato F
Cervical dysplasia Guunesenit camieestns E
f
Cervical intraepithelial neoplasia (CIN)
Chromosome plex ra
Chronic fatigue syndrome f
Cervical smears
Chronic obstructive pulmonary disease (COPD) £
T if ned C i 3 3
Cervical spine Chrysotile Ris! lisea
Churg-Strauss syndrome Afte afirluka
Cervix
Chagas’ disease
Chain E B Churg-Strauss-ike syndrome Leuk
CHAOS trial Vv
5] CIBIS-Ii trial { kers of benefit 1 lerate
Charity 4 € 1
4 #1 101 ae ) €
Charmac } € KI
Chemical pollution Vi
)
Chemicals wa Cidofovir Topical, f evere 1 \ tag
at
4 ] 4 mn
Chemokines Cigarettes Vegetabie-based and hazardt o he
; an et al 466 R); Warning packet
€ at anaca (Konor 388 N rE K t ]
Chemoprevention £ |! 5) Cingulate gyrus Abnormal activation a ated witt
tor lear g diff € tysiexia (N et a
Chemotherapy 4't
4 a 1¢ Ciprofioxacin-resistant Saimonelia typhi Treatment
f alu e (Threlfall et al 1590 R
M.Me ] Circadian rhythms Mechanisms, timing of sleep and
) " Morris 990 N): Probler elderly
elar - and trea f cturnal diur yé 46 (
of tane ipture f abdor 3 Manfredir
N ee a > a1 643 R) (Kario and Pickering 18
Chile Human rigt Manfredini et al 1800 C
Chi2meneerrails m PinMoicx ed € stic induce { Circdualmtconi si6o7n0 OC)f ne(Vwanb orHno web oysand ¢( Fisch1b67a0c her C); 669U S ( pol
yeloablative smatched bone
ransplantat oma (Falkenburg Cirrhosis Charmac poisoning causingg (2222 N
Brad) t and Kiuin-Nele jotoxaemia in and hyperfibrin«
Cheroots Birthweight reduct and (414 correct Chimpanzee H!V-1 Hepatocellular carcinoma risk factor
THE LANCET ~ Index to Vol 353 - 1999